NRIX
Nurix Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$26.80
−1.18%Leverage
- Debt / equity
- 0.07x
- Net debt / equity
- -0.68x
- Debt / assets
- 0.05x
- Debt / EBITDA
- 0.20x
- Net debt / EBITDA
- -2.03x
Liquidity & coverage
- Current ratio
- 8.44x
- Quick ratio
- 8.44x
- Cash ratio
- 8.02x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $973.0M
Cash & dividend
- FCF / debt
- 5.66x
- Cash flow / debt
- 5.81x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Aug 1, 2026